-
1
-
-
0037417523
-
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials
-
DOI 10.1016/S0140-6736(03)12113-7
-
Keeley EC, Boura JA, Grines CL,. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20. (Pubitemid 36050955)
-
(2003)
Lancet
, vol.361
, Issue.9351
, pp. 13-20
-
-
Keeley, E.C.1
Boura, J.A.2
Grines, C.L.3
-
2
-
-
73449142798
-
2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update)
-
2276-2277
-
Kushner FG, Hand M, Smith SC, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update). Circulation 2009; 120: 2271-2306, 2276-2277.
-
(2009)
Circulation
, vol.120
, pp. 2271-2306
-
-
Kushner, F.G.1
Hand, M.2
Smith, S.C.3
-
3
-
-
79952277824
-
Mesh covered stent in ST-segment elevation myocardial infarction
-
Dudek D, Dziewierz A, Rzeszutko L, et al. Mesh covered stent in ST-segment elevation myocardial infarction. EuroIntervention 2010; 6: 582-589.
-
(2010)
EuroIntervention
, vol.6
, pp. 582-589
-
-
Dudek, D.1
Dziewierz, A.2
Rzeszutko, L.3
-
4
-
-
77952127532
-
5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction
-
Ndrepepa G, Tiroch K, Fusaro M, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010; 55: 2383-2389.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 2383-2389
-
-
Ndrepepa, G.1
Tiroch, K.2
Fusaro, M.3
-
5
-
-
70349784488
-
The pericardium covered stent (PCS)
-
Colombo A, Almagor Y, Gaspar J, Vonderwalde C,. The pericardium covered stent (PCS). EuroIntervention 2009; 5: 394-399.
-
(2009)
EuroIntervention
, vol.5
, pp. 394-399
-
-
Colombo, A.1
Almagor, Y.2
Gaspar, J.3
Vonderwalde, C.4
-
7
-
-
78650027243
-
Percutaneous coronary aneurysm obliteration using a novel pericardium-covered stent
-
Ferlini M, Russo F, Marinoni B, et al. Percutaneous coronary aneurysm obliteration using a novel pericardium-covered stent. J Am Coll Cardiol 2010; 56: 2139.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 2139
-
-
Ferlini, M.1
Russo, F.2
Marinoni, B.3
-
8
-
-
70349559697
-
Treatment of ruptured coronary aneurysm with a novel covered stent
-
Hayat SA, Ghani S, More RS,. Treatment of ruptured coronary aneurysm with a novel covered stent. Catheter Cardiovasc Interv 2009; 74: 367-370.
-
(2009)
Catheter Cardiovasc Interv
, vol.74
, pp. 367-370
-
-
Hayat, S.A.1
Ghani, S.2
More, R.S.3
-
9
-
-
72649088624
-
Use of a novel pericardial covered stent to seal an iatrogenic coronary perforation
-
Jokhi P, McKenzie DP, O'Kane P,. Use of a novel pericardial covered stent to seal an iatrogenic coronary perforation. J Invasive Cardiol 2009; 21: E187-E190.
-
(2009)
J Invasive Cardiol
, vol.21
-
-
Jokhi, P.1
McKenzie, D.P.2
O'Kane, P.3
-
10
-
-
0033057201
-
Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy
-
DOI 10.1002/(SICI)1522-726X (199905)47:1<73::AID-CCD17>3.0.CO;2-Z
-
Gaspar J, Martinez-Rios MA, Vonderwalde C, et al. Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Catheter Cardiovasc Interv 1999; 47: 73-79. (Pubitemid 29309567)
-
(1999)
Catheterization and Cardiovascular Interventions
, vol.47
, Issue.1
, pp. 73-79
-
-
Gaspar, J.1
Martinez-Rios, M.A.2
Vonderwalde, C.3
Rosas, M.4
Ban-Hayashi, E.5
Eidt-Lidt, G.6
Kuri, J.7
-
11
-
-
0027396699
-
Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the thrombolysis in myocardial ischemia (timi iiia) trial
-
The TIMI IIIA Investigators
-
The TIMI IIIA Investigators. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) trial. Circulation 1993; 87: 38-52
-
(1993)
Circulation
, vol.87
, pp. 38-52
-
-
|